The Lancet Infectious Diseases

Title Publication Date Language Citations
Pathogenesis of infections due to coagulasenegative staphylococci2002/11/01English15
Clinical features and management of human monkeypox: a retrospective observational study in the UK2022/08/01English15
Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990–20162018/11/01English14
Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study2011/08/01English14
Incubation periods of acute respiratory viral infections: a systematic review2009/05/01English14
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial2021/12/01English14
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study2022/01/01English14
The value of antimicrobial peptides in the age of resistance2020/09/01English14
Alternatives to antibiotics—a pipeline portfolio review2016/02/01English14
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison2020/12/01English14
West Nile virus2002/09/01English14
Systematic reviews: CRD's guidance for undertaking reviews in health care2010/04/01English14
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study2020/09/01English14
Sepsis: a roadmap for future research2015/05/01English14
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis2012/01/01English13
Meningococcal carriage by age: a systematic review and meta-analysis2010/12/01English13
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial2021/02/01English13
The many estimates of the COVID-19 case fatality rate2020/07/01English13
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)2019/08/01English13
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial2021/07/01English13
Role of lipoteichoic acid in infection and inflammation2002/03/01English13
The global burden of dengue: an analysis from the Global Burden of Disease Study 20132016/06/01English13
Crimean-Congo haemorrhagic fever2006/04/01English13
Pathogenesis of influenza-induced acute respiratory distress syndrome2014/01/01English13
Changes in colistin resistance and mcr-1 abundance in Escherichia coli of animal and human origins following the ban of colistin-positive additives in China: an epidemiological comparative study2020/10/01English12
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies2018/07/01English12
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study2017/07/01English12
Obesity and infection2006/07/01English12
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials2021/08/01English12
Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study2020/10/01English12